Stop Designer Babies protests irresponsible summit plans to legalise human genetic modification
By GMWatch Staff,
GMWatch
| 03. 06. 2023
The anti-eugenics activist group, Stop Designer Babies (SDB),(1) is protesting today outside the ‘International Summit’ on human genetic modification (HGM).(2) SDB and its international partners are pledged to defend international Human Rights treaties and legislation in 70 countries banning HGM, (3) which were created because of the ongoing experience of eugenics. Today, SDB released research that demonstrates the links between the venue, the summit chair and the Eugenics Society, links which are doubly disturbing given that HGM was always a holy grail of eugenicists.
The research, published today on SDB’s website, details the eugenic views of Francis Crick, after whom the Summit venue is named, which should have prevented the Medical Research Council from naming the Institute after him. What is equally disturbing is that the summit chair, Robin Lovell-Badge, who made himself central to scientists’ efforts to legalise HGM,(4) gave the Eugenics Society Galton Lecture(5) in 2017. An article in last week’s Nature magazine hoped genome editing could move on after the scandal of He Jiankui’s announcement of the creation of three GM babies in 2019. But there is an...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...